Alzheimer's disease: RUO portfolio
With an emerging menu of Research Use Only (RUO) biomarker assays, Roche is committed to investigating and developing the global solutions that will help researchers find answers in the vast and complex area of neurology.
Roche’s current neurology RUO menu
View full tableRoche’s current neurology RUO menu
| 01 | 02 | 03 | 04 | 05 |
| AB42* Amyloid beta 42 |
GFAP* Glial fibrillary acidic protein |
NfL* Neurofilament light chain |
pTau 217* Phosphorylated Tau 217 |
YKL40* Chitinase 3-like 1 |
Additional assays available for research
View full tableAdditional assays available for research
| Neurology biomarkers | |
| Abeta40** | BD-Tau** |
| GDF-15** | IGFBP7** |
| Neurogranin** | NPTX2** |
| pTau217 (CSF)** | S100b** |
| SNAP 25** | sTREM-2** |
| tTau (plasma)** | |
These products are for Research Use Only and not for diagnostic procedures.